NIiksan Pharmaceutical is the world’s leading pharmaceutical company in the field of manufacturing, supplying and exporting of Lidocaineand API. Niksan pharmaceutical provides wide range of API and Finished pharmaceutical products of Lidocaineto the Niksan group companies and also to our customers in very affordable price. Niksan Pharmaceutical is the largest manufacturers, trader and supplier of Lidocaine in all-over Ankleshwar, Gujarat, India. Niksan Pharmaceutical manufacture and supplies Lidocaine product to the Indian states like Maharashtra, Goa, Sikkim, Assam,Haryana, Rajasthan, Karnataka,Madhya Pradesh, Uttar Pradesh, Rajasthan, Punjab, Delhi, Bihar, Meghalaya, Tamilnadu, Kerala, Gujarat, , and other states. Niksan Pharmaceutical is manufacturer, suppliers and exporters of Lidocaine in many countries from many years like United States, Puerto Rico, Netherlands, Lebanon, Canada, Philippines, Belgium, Ireland, Iraq, United Arab Emirates, Jordan, United Kingdom, Nigeria, Saudi Arabia, France , Egypt, Pakistan, Singapore, 'Taiwan, China', South Korea , Australia, New Zealand, Morocco, Israel, Bangladesh, Malaysia, Algeria, Thailand, South Africa, Switzerland, 'Hong Kong, S.A.R., China', Iran, Indonesia, Sweden, Romania, Vietnam, Poland, Germany, Mexico, Italy, Turkey, Spain, Brazil, Japan and many more countries. Lidocaine is a drug used as local anaesthetics. Lidocaine works by causing temporary loss of feeling on the area where it applied. Lidocaine blocks the nerve signals of your body. Lidocaine mostly used as a topical agent who reduce the pain of skin caused by sun burn, poison oak, poison ivy, poison sumac, scratches, insect bites etc. SYNONYMS: Lidocaína, Lidocaina, Lidocaine, Lidocainumm, Lignocaine IUPAC NAME:2-(diethyl amino)-N-(2,6-dimethylphenyl)acetamide CAS NO:137-58-6 FORMULA:C14H22N2O MOLECULAR MASS: 234.343 g/mol STORAGE CONDITIONS:Storein cool and dry place away from direct heat and light.Do not put medicine in bathroom or humid place.Keep away from children and pets. HOW TO USE:TouseLidocaine cream, wash and dry your hand properly before applying thecream. Do not consume it. Apply this cream gently and rub it for some time. If you are using patches use only once and after discard it. HOW LIDOCAINE WORKS:Lidocainereduces the pain of body by giving the anaesthetic effect.Lidocaine works by blocking the nerves of the particular part where Lidocaine is applied. PHARMACOKINETICS:Lidocaine rapidly absorbed through the damaged skin but poorly absorbed on the intact skin. Lidocaine quickly absorbed in the GI track after the oral administration and the bioavaibility of Lidocaine is 35%.Almost 60-80% of drug binds with the blood plasma proteins.The half-life of the medicine is between 1.5-2 hours.Only 5% of unchanged drug eliminated through the kidney. SIDE EFFECTS OF LIDOCAINE: Lidocaine cause little redness, numbness or swelling on the particular area. If these effects persist tell your doctor about it.Take the medical help if you see side effects like slow heartbeats, grey/bluish skin, and trouble in breathing, fever, tiredness.The allergic reactions are rare but if you see effects like rash, itching or swelling the skin contact your doctor. PRECAUTIONS:Tell your doctor if you have any allergic reactions to Lidocaine.Before taking this medication tell your doctor if you have any problems like diabetes, heart problem, liver problem, eye problem, blood disorder or any stomach problem.Children have more side effects to the Lidocaine, so kindly give medicine after talking to your doctor. CDSCO APPROVAL: Cross linked Hyaluronic Acid 24mg + Lidocaine 3mg Pre-filled syringes approved by CDSCO in India in 28.05.2010, Lidocaine Patch 350mg (Additional Pack Size) approved by CDSCO in India in 17.06.2010, Lidocaine Lozenges 100mg (Additional Strength) approved by CDSCO in India in 15.07.2010, Lidocaine Lozenges 200/300mg (Addl. Indication) approved by CDSCO in India in 19.08.2009, Lidocaine HCl Ophthalmic Sterile Gel 35 mg/ml approved by CDSCO in India in 30.07.10, Lidocaine patch 5% approved by CDSCO in India in 31.03.2009, Lidocaine7.5mg + Prilocaine2.5mg per actuation spray approved by CDSCO in India in 12.03.2010, Lidocaine Lozenges 200/300mg approved by CDSCO in India in 26.02.2009, Nifedipine 0.3% + Lidocaine1.5% cream approved by CDSCO in India in 26.02.2009, Lidocaine 2% + prilocaine 2.5% w/w cream approved by CDSCO in India in 1999-May, Lidocaine Patch 700mg in aqueous base (50 mg per gram adhesive) approved by CDSCO in India in 26.03.2009, Lidocaine 2.5% w/w + Prilocaine 2.5% w/w Gel approved by CDSCO in India in 26.03.10 FORMULATIONS AVAILABLE IN MARKET: Cross linked Hyaluronic Acid 24mg + Lidocaine 3mg Pre-filled syringes Lidocaine Patch 350mg Lidocaine Lozenges 100mg Lidocaine Lozenges 200mg Lidocaine Lozenges 300mg Lidocaine HCl Ophthalmic Sterile Gel 35 mg/ml Lidocaine patch 5% Lidocaine7.5mg + Prilocaine2.5mg per actuation spray Nifedipine 0.3% + Lidocaine1.5% cream Lidocaine 2% + prilocaine 2.5% w/w cream Lidocaine Patch 700mg in aqueous base Lidocaine 2.5% w/w + Prilocaine 2.5% w/w Gel Note: Product protected by valid patents are not offered for sale in countries where such patents are still valid and its liability is at Buyers Risk REFERENCES: www.webmd.com https://pubchem.ncbi.nlm.nih.gov https://go.drugbank.com https://cdscoonline.gov.in https://www.wikipedia.org/ https://www.drugs.com https://www.zaubacorp.com https://www.practo.com/consult |